CytomX Therapeutics, Inc.CTMXNASDAQ
Loading
Net Income ContractionContracting
Percentile Rank75
Studio
Year-over-Year Change

Total earnings after all expenses, taxes, and interest

Latest
$-17.37M
↑ 69% vs avg
Percentile
P75
Within normal range
Streak
1 yr
Consecutive declineContracting
Average
$-55.49M
Historical baseline
PeriodValueYoY Change
TTM$-17.37M-154.5%
2024$31.87M+5700.9%
2023$-569000.00+99.4%
2022$-99.32M+14.3%
2021$-115.87M-78.8%
2020$-64.82M+36.6%
2019$-102.24M-20.8%
2018$-84.60M-96.3%
2017$-43.10M+26.8%
2016$-58.90M-